BCI-1229

N/A

Report date: 2025/01/26 18:26:17
NME

Base Information

Drug NameBCI-1229
Drug Alias NameCSF1R inhibitors (BCI-Pharma)BCI-1229
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitorsProtein-tyrosine kinases inhibitors
TargetsMacrophage Colony Stimulating Factor 1Protein-tyrosine kinases
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBCI Pharma
China Registration ClassN/A

Develop Information

Active CompaniesGedeon Richter Plc
Inactive CompaniesBCI Pharma
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A